Recruiting PHASE3 INTERVENTIONAL 2-arm
NCT07040137
Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration
Phase III Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration
Sponsor: Kissei Pharmaceutical Co., Ltd.
Conditions
Spinocerebellar Degeneration
Updated 1 time since 2025 Last updated: Jun 25, 2025 Started: Jul 31, 2025 Primary completion: Mar 31, 2027 Completion: Mar 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE3 clinical study on Spinocerebellar Degeneration, this trial is actively recruiting participants. The trial is conducted by Kissei Pharmaceutical Co., Ltd. and has accumulated 1 data snapshot since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Recruiting — PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Kissei Pharmaceutical Co., Ltd.
Data source: Kissei Pharmaceutical Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .